Pliant Therapeutics, Inc. (PLRX) Tops Q4 EPS by 1c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q4 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
• Realty Income (O) Reiterated at Neutral by Cantor Fitzgerald as New JV Announced
• H.C. Wainwright Reiterates Buy Rating on Niagen Bioscience (NAGE)